EurekAlert! -
28 Jul 2017 06:00
(Duke University Medical Center) The push to develop treatments for Alzheimer's disease has yielded a greater understanding of the disease, but has failed to generate successful new drugs.To blame are the many undefined subtypes of mild cognitive impairment, a precursor to Alzheimer's disease. But if scientists grouped people with similar types of cognitive impairment, they could more precisely test the impact of investigational drugs, according to findings in a July 28 article in the journal Sc...
Share this Article